Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

GE HealthCare to acquire Sofie Biosciences for $945M

6 October 2026 · By · Wire by Fusion42

Published

6 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at biopharmadive.com →

◆ Verified

Fusion42 · 6 October 2026 · Fusion42 review

GE HealthCare is acquiring Sofie Biosciences for $945 million to enhance its radiopharmaceutical capabilities, focusing on manufacturing and distributing time-sensitive drugs used in PET imaging.

This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 5 Oct 2026 and 6 Oct 2026.

◆ ◆ The Wire takeaway

You face new pressure to offer integrated radiopharmaceutical solutions at speed. This deal opens the door to compete with GE’s expanded footprint in PET drug manufacturing and distribution.

◆ Coverage

4 sources · first reported 5 Oct 2026 · latest 6 Oct 2026

◆ Related on Wire

◆ Topics

Medtechm-aradiopharmaceuticalsmedical-imagingpet-imagingmedtech